Digital Therapeutics Alliance Summit to go to Washington DC in 2024

The Digital Therapeutics Alliance will take its 2024 Digital Therapeutics Alliance Summit to the Washington Marriott Metro Center in DC, 5-7 June, 2024. This annual event aims to address the commercialisation challenges in the digital therapeutics industry. The 2024 DTA Summit will offer interactive workshops, thought leadership and bring experts, industry leaders, and innovators together to collaborate on advancing this rapidly evolving sector. The 2024 Summit will feature interactive workshops where delegates can get hands-on experience in the latest digital therapeutics tools, methodologies, and best practices. They can also understand the strategies, opportunities, and obstacles in bringing digital therapeutics to market, with insights from experts who have successfully navigated these waters, as well as taking advantages of many networking opportunities. Mandy Harvey (pictured), a deaf jazz singer, will be the keynote speaker at the Summit and will tell her story of overcoming barriers and achieving success in the world of music. She will highlight her resilience, determination, and the power of human potential. The Summit is supported by Curavit Clinical Research, a research and development company in the field of digital therapeutics. Organisers have also announced a media partnership with Healio, a source of healthcare news and information. Healio’s support will help ensure that the insights and knowledge shared at the summit reach a wide and engaged audience. Registration for the Summit opens 1 November. Visit 2024 DTA Summit for full details. The Digital Therapeutics Alliance is a global non-profit organisation with the mission to drive the adoption of high-quality digital therapeutics into mainstream healthcare.